Search
Fibracillin
go.drugbank.com/drugs/DB21302ExperimentalFibracillin is a small molecule drug. The usage of the INN stem '-cillin' in the name indicates that Fibracillin is a antibiotic, 6-aminopenicillanic acid derivative.
Ipazilide
go.drugbank.com/drugs/DB21330ExperimentalIpazilide is a small molecule drug. The usage of the INN stem '-ilide' in the name indicates that Ipazilide is a sematilide derivative class III antiarrhythmic.
Pidobenzone
go.drugbank.com/drugs/DB21369ExperimentalPidobenzone is a small molecule drug. The usage of the INN stem '-zone' in the name indicates that Pidobenzone is a anti-inflammatory analgesic, phenylbutazone derivative.
Trifezolac
go.drugbank.com/drugs/DB21380ExperimentalTrifezolac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Trifezolac is a anti-inflammatory agent, ibufenac derivative.
Pulrodemstat
go.drugbank.com/drugs/DB21497ExperimentalPulrodemstat is a small molecule drug. The usage of the INN stem '-demstat' in the name indicates that Pulrodemstat is a Lysine-specific histone demethylase inhibitor.
Zavolosotine
go.drugbank.com/drugs/DB21531ExperimentalZavolosotine is a small molecule drug. The usage of the INN stem '-sotine' in the name indicates that Zavolosotine is a non-peptidic somatostatin receptor agonist.
Branosotine
go.drugbank.com/drugs/DB21674ExperimentalBranosotine is a small molecule drug. The usage of the INN stem '-sotine' in the name indicates that Branosotine is a non-peptidic somatostatin receptor agonist.
Eltrekibart
go.drugbank.com/drugs/DB19017InvestigationalEltrekibart is under investigation in clinical trial NCT06046729 (A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa).
Cavosonstat
go.drugbank.com/drugs/DB14775InvestigationalCavosonstat is under investigation in clinical trial NCT02589236 (Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation).
Bermekimab
go.drugbank.com/drugs/DB14947InvestigationalBermekimab is under investigation in clinical trial NCT01384630 (Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis).